Evidence map›Paper›PMID 26769308›Full record

ReviewCurrent rheumatology reports2016

Causality of Chlamydiae in Arthritis and Spondyloarthritis: a Plea for Increased Translational Research.

Henning Zeidler, Alan P Hudson

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current rheumatology reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Antibiotics for Rheumatologic Diseases: A Critical Review.International journal of molecular sciences · 2025
    Review
  3. [Reactive arthritis].Zeitschrift fur Rheumatologie · 2025
    Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Microorganisms · 2019
    Review
  9. Review
  10. Article
  11. [Update on reactive arthritis].Zeitschrift fur Rheumatologie · 2016
    Review
  12. Review
  13. [Classification criteria for rheumatic diseases].Zeitschrift fur Rheumatologie · 2016
    Review
  14. Indian dermatology online journal
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Henning ZeidlerDivision of Clinical Immunology and Rheumatology, Hannover Medical School, Carl-Neuberg-Straße 1, 30625, Hannover, Germany. zeidler.henning@mh-hannover.de.
Alan P HudsonDepartment of Immunology and Microbiology, Wayne State University School of Medicine, Detroit, MI, USA.
Medizinische Hochschule Hannover · DEWayne State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Current molecular genetic understanding of the metabolically active persistent infection state of Chlamydia trachomatis and Chlamydia pneumoniae in the synovium in patients with arthritis and spondyloarthritis favors a causal relationship. Here, we examine how adequately the accepted criteria for that etiologic relationship are fulfilled, emphasizing the situation in which these microorganisms cannot be cultivated by standard or other means. We suggest that this unusual situation of causality by chlamydiae in rheumatic disease requires establishment of a consensus regarding microorganism-specific terminology as well as the development of new diagnostic and classification criteria. Recent studies demonstrate the value of molecular testing for diagnosis of reactive arthritis, undifferentiated spondyloarthritis, and undifferentiated arthritis caused by C. trachomatis and C. pneumoniae in clinical practice. Data regarding combination antibiotic therapy is consistent with the causative role of chlamydiae for these diseases. Observations of multiple intra-articular coinfections require more research to understand the implications and to respond to them.

Indexed as

Chlamydia trachomatisChlamydophila pneumoniaeAnti-Bacterial AgentsArthritis, ReactiveChlamydia InfectionsChronic DiseaseDrug Therapy, CombinationHumansSpondylarthritisTerminology as TopicTranslational Research, BiomedicalAnti-Bacterial AgentsAntibiotic combination therapyChlamydia arthritisChlamydia pneumoniaeChlamydia spondyloarthritisChlamydia trachomatisCoinfectionReactive arthritisSlow bacterial infectionSpondyloarthritis

Identifiers

PMID26769308
OpenAlexW2269827110

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.